Breaking News Instant updates and real-time market news.

GE

General Electric

$29.64

-0.6345 (-2.10%)

, BHI

Baker Hughes

$58.02

-1.48 (-2.49%)

12:31
04/21/17
04/21
12:31
04/21/17
12:31

On The Fly: Top stock stories at midday

Stocks have been in a holding pattern since the open as the trading range was narrow all morning. The lack of volatility is a victory for the bulls after yesterday's big advance and the market's move this week, which has put the S&P on target for its biggest weekly advance in two months. The Nasdaq hit another new all-time high earlier in the session, as it has several times this week. Oil prices are renewing their downtrend and are lower by more than 2% for the day to slip below $50 per barrel. ECONOMIC NEWS: In the U.S., Markit's manufacturing PMI dipped 0.5 points to 52.8 in the April flash reading, missing the consensus forecast for a rise to 53.8. Existing home sales rebounded 4.4% to a 5.71M rate in March, recovering from the 3.9% decline to a 5.47M rate in February. In Asia, Japan's manufacturing PMI rose to 52.8 in April on a seasonally adjusted basis, from a final 52.4 in the previous month. In Europe, Markit's flash Eurozone PMI manufacturing index for April strengthened to 56.8 from the March reading of 56.2. COMPANY NEWS: Shares of General Electric (GE) have dropped 2% despite the fact that the industrial giant beat first quarter earnings expectations. The company's chairman and CEO Jeff Immelt also said the company's planned merger of its Oil & Gas division with Baker Hughes (BHI) remains on track... Conversely, shares of Honeywell (HON) have gained about 2.5% after the diversified manufacturer announced better than expected quarterly profit as sales in the company's aerospace and energy businesses came in above forecast... Also higher after earnings is Visa (V), which has advanced 0.5% after beating quarterly earnings and revenue estimates. The company also announced a $5B buyback of class A common stock. MAJOR MOVERS: Among the notable gainers was Hawaiian Holdings (HA), which advanced over 4% after the parent company of Hawaiian Airlines posted stronger than expected earnings for the quarter. Also higher was Rockwell Collins (COL), which gained over 4% after beating quarterly estimates and raising its guidance. Additionally, Proofpoint (PFPT) gained almost 8% after the company's results and outlook topped expectations. Among the noteworthy losers was Mattel (MAT), which slid more than 11% following another quarter of lower sales. Also lower was Manhattan Associates (MANH), which slipped about 8% following quarterly results. INDEXES: Near midday, the Dow was down 15.23, or 0.07%, to 20,563.48, the Nasdaq was down 6.19, or 0.10%, to 5,910.59, and the S&P 500 was down 5.73, or 0.24%, to 2,350.11.

GE

General Electric

$29.64

-0.6345 (-2.10%)

BHI

Baker Hughes

$58.02

-1.48 (-2.49%)

HON

Honeywell

$127.00

3.23 (2.61%)

V

Visa

$91.55

0.4 (0.44%)

HA

Hawaiian Holdings

$51.90

1.4 (2.77%)

COL

Rockwell Collins

$103.90

4.31 (4.33%)

PFPT

Proofpoint

$71.00

-6.62 (-8.53%)

MAT

Mattel

$25.21

0.1 (0.40%)

MANH

Manhattan Associates

$50.58

0.02 (0.04%)

  • 21

    Apr

  • 21

    Apr

  • 21

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 09

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 18

    May

  • 22

    Jun

  • 22

    Jun

GE General Electric
$29.64

-0.6345 (-2.10%)

04/10/17
FBRC
04/10/17
NO CHANGE
FBRC
FBR views Tesco as most likely takeover in Oilfield Services
FBR Capital analyst Thomas Curran says that within his Oilfield Services coverage, Tesco (TESO) has the highest probability of a straight acquisition. In GE Oil & Gas (GE) and Forum Energy (FET), Tesco has at least two potential strategic acquirers with "highly compelling logic," Curran tells investors in a research note. He believes a buyer could offer $10 per share. Tesco closed Friday at $7.30.
03/31/17
WBLR
03/31/17
NO CHANGE
WBLR
Outperform
General Electric shares set to move higher, says William Blair
William Blair analyst Nicholas Heymann believes shares of General Electric are set to move higher, not on management changes, but stronger fundamentals as the "external macro environment continues to improve." If GE achieves its more aggressive 2017 fundamental performance hurdles, the shares should be set to move steadily higher to the mid- to upper $30s, Heymann tells investors in a research note. The analyst sees potential upside to estimates from U.S. corporate tax reform and U.S. privately financed infrastructure modernization. He keeps an Outperform rating on GE shares.
03/28/17
JPMS
03/28/17
NO CHANGE
Target $27
JPMS
Underweight
General Electric price target lowered to $27 from $29 at JPMorgan
JPMorgan analyst C. Stephen Tusa lowered his price target for General Electric to $27 and keeps an Underweight rating on the shares. The sell-side bull thesis is shifting focus away from the $2.00 earnings per share target in 2018 to free cash flow, which is "seemingly appropriately," Tusa tells investors in a research note. The analyst views the emerging bull case on free cash flow as "overstated and not plausible." He notes his new $27 price target still implies a premium 4% free cash yield and "solid" 3.5% dividend yield.
03/13/17
JPMS
03/13/17
NO CHANGE
Target $29
JPMS
Underweight
JPMorgan says use GE rally as selling opportunity
JPMorgan analyst C. Stephen Tusa recommends using Friday's rally in General Electric shares as a selling opportunity. A possible CEO change does not change the analyst's view that GE is an expensive stock. Discussion of an activist, who owns less than 1% of the company, trying to make changes is a re-run of the case made two years ago, Tusa tells investors in a research note. The analyst does not see much a GE activist can do. The company's "stubbornly low growth and secular challenges embedded in end markets" can't be fixed by a CEO, the analyst contends. Tusa keeps an Underweight rating on shares of GE with a $29 price target. The stock rallied Friday to $30.28 after Fox Business reported that CEO Jeff Immelt is on the "hot seat" with activist Nelson Peltz.
BHI Baker Hughes
$58.02

-1.48 (-2.49%)

02/09/17
02/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIA, VIAB) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying the company's first quarter results prove its turnaround is "real and likely to continue." The strategic plan put in place by CEO Bakish makes sense, Ryvicker tells investors in a research note. The analyst raised his price target range for the shares to $48-$50 from $38-$40. 2. Micron (MU) upgraded to Buy from Underperform at BofA/Merrill. 3. Sanofi (SNY) upgraded to Buy from Neutral at Natixis. 4. Hawaiian Holdings (HA) upgraded to Outperform from Peer Perform at Wolfe Research. 5. Baker Hughes (BHI) upgraded to Positive from Neutral at Susquehanna with analyst Charles Minervino citing the selloff in shares and its upside opportunity associated with a US spending upcycle, synergies from its joint-venture with General Electric (GE), and the growth opportunities that could develop from a partnership with a diversified global oilfield services company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/19/17
HSBC
04/19/17
INITIATION
Target $62
HSBC
Hold
Baker Hughes initiated with a Hold at HSBC
HSBC analyst David Phillips initiated Baker Hughes with a Hold and a $62 price target due to valuation and said there are few impediments to the GE merger completion.
04/19/17
04/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ING Group (ING) initiated with a Buy at Jefferies. 2. T-Mobile (TMUS) was initiated with a Buy at SunTrust while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 3. DXC Technology (DXC) initiated with an Overweight at JPMorgan. 4. LendingClub (LC) coverage resumed with a Hold at Stifel. 5. Halliburton (HAL) and Schlumberger (SLB) were initiated with a Buy at HSBC while Baker Hughes (BHI) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/17
SUSQ
02/09/17
UPGRADE
Target $71
SUSQ
Positive
Baker Hughes upgraded to Positive on selloff at Susquehanna
As reported previously, Susquehanna analyst Charles Minervino upgraded Baker Hughes (BHI) to Positive from Neutral. The analyst cited the selloff in shares and its upside opportunity associated with a US spending upcycle, synergies from its joint-venture with General Electric (GE), and the growth opportunities that could develop from a partnership with a diversified global oilfield services company. Minervino raised his price target to $71 from $70 on Baker Hughes shares.
HON Honeywell
$127.00

3.23 (2.61%)

12/13/16
UBSW
12/13/16
NO CHANGE
UBSW
Neutral
Earlier than expected Boeing 777 rate cut negative for suppliers, says UBS
UBS analyst David Strauss said that while Boeing (BA) had previously signaled a 777 production rate cut was coming, he thinks the now-announced cut to 5 planes per month in mid-2017 is 3 to 6 months earlier than expected. He sees the earlier than expected transition as having negative implications for key 777 suppliers, including B/E Aerospace (BEAV), GE (GE), Honeywell (HON), Spirit AeroSystems (SPR) and Triumph Group (TGI). Strauss keeps a Neutral rating on Boeing, as he believes 777X development will burn a couple billion per year with overall FCF declining during this period, but also said the company's 30% dividend increase and $14B buyback announcement signals strong confidence in its cash flow outlook.
02/21/17
JEFF
02/21/17
NO CHANGE
Target $141
JEFF
Buy
Honeywell price target raised to $141 from $133 at Jefferies
Jefferies analyst Howard Rubel raised his price target for Honeywell to $141 following a review of the company's annual filing. The 10-K highlights elements of profitability and cash flows, Rubel tells investors in a research note. He expects the non-U.S. business will continue to be more profitable show better growth. Rubel keeps a Buy rating on Honeywell.
03/02/17
OPCO
03/02/17
NO CHANGE
Target $148
OPCO
Outperform
Honeywell price target raised to $148 from $134 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Honeywell to $148 from $134 as OM track record exceeds new commitments, organic outlook appears conditioned by recent years' macro headwinds. Further, with defense spending set to turn and Honeywell indicating AM outgrowth of flight hours this year, the analyst thinks an upward tweak of Aero guide could materialize during 2017. He reiterates an Outperform rating on the shares.
12/19/16
OPCO
12/19/16
NO CHANGE
Target $134
OPCO
Outperform
Honeywell price target raised to $134 from $122 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Honeywell to $134 from $122, citing its 2017 outlook as he believes quality of drivers are set to improve. He reiterates an Outperform rating on the shares.
V Visa
$91.55

0.4 (0.44%)

04/21/17
BERN
04/21/17
NO CHANGE
BERN
Visa price target raised to $110 from $105 at Bernstein
Bernstein analyst Lisa Ellis says that Visa reported "strong" results, and the analyst expects the stock's positive momentum to continue going forward. She raised her price target on the shares to $110 from $105 and continues to identify the stock as her top pick.
04/21/17
FBCO
04/21/17
NO CHANGE
Target $105
FBCO
Outperform
Visa price target raised to $105 from $100 at Credit Suisse
Credit Suisse analyst Moshe Orenbuch raised his price target for Visa to $105 from $100 following a Q2 beat on higher revenues and lower taxes. The analyst reiterates an Outperform rating on the shares.
04/21/17
OPCO
04/21/17
NO CHANGE
Target $100
OPCO
Outperform
Visa price target raised to $100 from $95 at Oppenheimer
Oppenheimer analyst Glenn Greene raised his price target for Visa to $100 from $95 after the company reported strong upside Q2 results. The analyst reiterates an Outperform rating on the shares.
04/19/17
OPCO
04/19/17
NO CHANGE
OPCO
Oppenheimer bullish on Visa, MasterCard ahead of results
Oppenheimer analyst Glenn Greene reiterates Outperform ratings for MasterCard (MA) and Visa (V) and $120 and $95 price targets, respectively, heading into results. The analyst is encouraged by "solid" January intra-quarter volume growth, improving gas price trends, strong retail sales growth, and broadly positive card issuer trends. Further, Greene continues to believe that MasterCard and Visa are attractive at current levels, given their defensible market positions and strong long-term prospects. Nonetheless, he prefers Visa relative to MasterCard at present given the continuing U.S. volume boost from the Costco (COST)/USAA wins and JPMorgan Chase (JPM) Sapphire Reserve momentum, apparent conservative guidance, and Visa Europe accretion benefits.
HA Hawaiian Holdings
$51.90

1.4 (2.77%)

02/09/17
WOLF
02/09/17
UPGRADE
WOLF
Outperform
Hawaiian Holdings upgraded to Outperform from Peer Perform at Wolfe Research
04/21/17
BUCK
04/21/17
UPGRADE
BUCK
Buy
Hawaiian Holdings upgraded to Buy from Neutral at Buckingham
04/21/17
04/21/17
UPGRADE

Buy
Hawaiian Holdings upgraded on valuation, fundamental strength at Buckingham
As previously reported, Buckingham upgraded Hawaiian Holdings to Buy from Neutral and raised its price target to $63 from $55. The firm said there is a valuation disconnect as shares are down 9% year-to-date and underlying fundamentals remain strong. Buckingham's analyst has reduced concerns about competitive capacity between Hawaii and Japan due to domestic momentum and international strength elsewhere and raised estimates saying revenue is trending wall above forecasts.
COL Rockwell Collins
$103.90

4.31 (4.33%)

04/04/17
UBSW
04/04/17
NO CHANGE
Target $122
UBSW
Buy
Rockwell Collins price target raised to $122 from $108 at UBS
UBS analyst David Strauss raised his price target on Rockwell Collins (COL) to $122 from $108 on expectations the B/E Aerospace (BEAV) acquisition will close over the near-term, leading to higher earnings estimates and free cash flow. Strauss maintained his Buy rating on Rockwell Collins shares.
04/19/17
BARD
04/19/17
UPGRADE
Target $118
BARD
Outperform
Rockwell Collins upgraded to Outperform from Neutral at Baird
Baird analyst Peter Arment upgraded Rockwell Collins to Outperform from Neutral to reflect the recently closed acquisition of B/E Aerospace, which he views as having compelling accretion and cash flow generation. Arment believes investors should add or establish positions in Rockwell Collins below $100 per share and he raised his price target to $118 from $90.
03/20/17
FBCO
03/20/17
UPGRADE
FBCO
Outperform
Rockwell Collins upgraded to Outperform from Neutral at Credit Suisse
03/20/17
03/20/17
UPGRADE
Target $120

Outperform
Rockwell Collins upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Spingarn upgraded Rockwell Collins (COL) to Outperform from Neutral as he expects a series of positive catalysts over the next 12 months. The analyst also sees a "strong pro-forma financial profile" with the ability to quickly delever, and says the B/E Aerospace (BEAV) acquisition is not priced in. Spingarn raised his price target on Rockwell Collins' to $120 from $92.
PFPT Proofpoint
$71.00

-6.62 (-8.53%)

04/21/17
RBCM
04/21/17
NO CHANGE
RBCM
Proofpoint reported 'impressive' Q1 results, says RBC Capital
RBC Capital analyst Matthew Hedberg says that Proofpoint reported "impressive" Q1 results and guidance. The analyst thinks that the company has many growth drivers going forward, and he keeps a $92 price target and an Outperform rating on the shares.
04/20/17
BARD
04/20/17
DOWNGRADE
BARD
Neutral
Proofpoint downgraded to Neutral from Outperform at Baird
04/20/17
BARD
04/20/17
DOWNGRADE
Target $77
BARD
Neutral
Proofpoint downgraded to Neutral at Baird
As reported previously, Baird analyst Jayson Noland downgraded Proofpoint to Neutral from Outperform citing concerns about sales execution that have accelerated lately. The analyst sees downside risk to earnings, though he said the company is still best-in-class in network security. Noland lowered his price target to $77 from $92 on Proofpoint shares.
04/21/17
PIPR
04/21/17
NO CHANGE
Target $90
PIPR
Overweight
Proofpoint remains a top pick for 2017 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski says Proofpoint remains a top pick for 2017 after reporting "yet another solid quarter." He believes the company has multiple growth drivers that are still in the early innings and that consensus estimates remain conservative. The analyst reiterates an Overweight rating on Proofpoint with a $90 price target.
MAT Mattel
$25.21

0.1 (0.40%)

02/13/17
GSCO
02/13/17
INITIATION
Target $27
GSCO
Neutral
Mattel initiated with a Neutral at Goldman
Goldman analyst Michael Ng initiated Mattel with a Neutral and a $27 price target. The analyst said Mattel is undergoing a turnaround in several of its core brands but consensus estimates are already looking for a meaningful recovery, creating increased risk.
02/08/17
PIPR
02/08/17
NO CHANGE
PIPR
Piper discusses resurfacing of Hasbro, Mattel deal speculation
Piper Jaffray analyst Stephanie Wissink points out that over her firm's 15 years of coverage, speculation of a merger between Hasbro (HAS) and Mattel (MAT) has surfaced several times. Hasbro's strong Q4 earnings report and share rally, in contrast with Mattel's negative Q4 preannouncement and pullback, has reignited the conjecture, Wissink tells investors in a research note. Economically a merger would create value, but a combination of the number two and three toy companies "would require significant evaluation from anti-trust authorities," the analyst writes. She believes a deal is possible if the Federal Trade Commission widens the boundaries around "youth entertainment & play," say to include video games, digital games and media. Hasbro closed yesterday up 67c to $94.98 while Mattel, after rallying in early trading, closed down 4c to $25.88. Wissink adds that she can find upwards of $500M of merger synergies if the two companies were to combine.
03/14/17
UBSW
03/14/17
NO CHANGE
UBSW
Buy
UBS discusses scenarios for hypothetical Mattel/Hasbro merger
UBS analyst Arpine Kocharyan noted market speculation about a potential merger of Hasbro (HAS) and Mattel (MAT). While admitting she has no view on the possibility of a deal happening, she does say there is large equity valuation gap between the two, with Mattel pricing in a potential dividend cut, and expressed her view that industry consolidation could pick up in 2017. Koocharyan maintains her Buy rating on Mattel and Neutral rating on Hasbro shares.
02/13/17
02/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Air Products (APD) reinstated with an Overweight at Barclays. 2. Hasbro (HAS) was initiated with a Buy at Goldman, while Mattel (MAT) was initiated with a Neutral. 3. Jagged Peak Energy (JAG) initiated with a Positive at Susquehanna. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at Wunderlich. 5. HollyFrontier (HFC) reinstated with a Sell at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
MANH Manhattan Associates
$50.58

0.02 (0.04%)

01/26/17
BMUR
01/26/17
NO CHANGE
Target $75
BMUR
Buy
Manhattan Associates services weakness likely to linger, says Brean Capital
Brean Capital analyst Yun Kim said his most recent channel checks for Manhattan Associates indicate services weakness remains and may linger. He said the checks also indicate the issues behind the weakness are temporary and not reflective of any decline in fundamentals. Kim believes the risk/reward at current valuation levels favor the long-term opportunity around the Omni-channel secular trend, which should offset the risks related to the current weakness. Kim reiterated his Buy rating and $75 price target on Manhattan Associates shares.
04/21/17
04/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Hold from Buy at Argus with analyst Joseph Bonner citing the company's subscriber losses and "intense competition." He says that the company has been forced to offer "unsubsidized phone plans and unlimited data" which have hurt its results. 2. Cabot Oil & Gas (COG) downgraded to Outperform from Strong Buy at Raymond Jame with analyst John Freeman citing recent outperformance and lower natural gas pricing forecasts. 3. Manhattan Associates (MANH) downgraded to Hold from Buy at Benchmark with analyst Mark Schappel noting that the company's cut to its 2017 revenue outlook was its third consecutive guide down. Schappel lowered his price target on Manhattan Associates shares to $48 from $65. 4. Humana (HUM) downgraded to Hold from Buy at Jefferies with analyst David Windley saying he views the as expensive and points out that 2018 premium growth under President Trump is lower than 2017 under Obama. 5. Plains All American (PAA) downgraded to Hold from Buy at Jefferies with analyst Christopher Sighinolf saying the valuation appears full at current share levels. The analyst lowered his price target for the name to $27 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/21/17
BNCH
04/21/17
DOWNGRADE
Target $48
BNCH
Hold
Manhattan Associates downgraded to Hold from Buy at Benchmark
Benchmark analyst Mark Schappel downgraded Manhattan Associates to Hold from Buy, noting that the company's cut to its 2017 revenue outlook was its third consecutive guide down. Schappel lowered his price target on Manhattan Associates shares to $48 from $65.
02/01/17
BNCH
02/01/17
NO CHANGE
Target $65
BNCH
Buy
Manhattan Associates price target lowered to $65 from $71 at Benchmark
Benchmark analyst Mark Schappel acknowledges he considered stepping aside with a downgrade of Manhattan Associates after the company's earnings report and "meaningfully lower" revenue outlook for 2017, but he believes the services business will bottom in Q1, allowing for a resumption of growth in the second half of the year if management executes. He keeps a Buy rating on Manhattan Associates shares, but cut his price target to $65 from $71 on the stock.

TODAY'S FREE FLY STORIES

AAPL

Apple

$146.28

0.65 (0.45%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

13:47
06/24/17
06/24
13:47
06/24/17
13:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$146.28

0.65 (0.45%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

GOOG

Alphabet

$965.59

8.5 (0.89%)

MSFT

Microsoft

$71.21

0.95 (1.35%)

IBM

IBM

$154.11

-0.29 (-0.19%)

MA

MasterCard

$124.01

0.71 (0.58%)

ORCL

Oracle

$50.95

0.65 (1.29%)

VMW

VMware

$90.92

0.48 (0.53%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AKAM

Akamai

$51.30

1.28 (2.56%)

SAP

SAP

$107.48

0.42 (0.39%)

QCOM

Qualcomm

$56.91

0.44 (0.78%)

ADBE

Adobe

$145.41

1.72 (1.20%)

ACN

Accenture

$122.74

0.66 (0.54%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

CYH

Community Health

$9.33

0.06 (0.65%)

THC

Tenet

$18.52

-0.38 (-2.01%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

UHS

Universal Health

$115.43

0.22 (0.19%)

AET

Aetna

$152.10

-0.88 (-0.58%)

WCG

WellCare

$183.28

-0.32 (-0.17%)

CI

Cigna

$169.61

-1.07 (-0.63%)

HUM

Humana

$238.42

1.42 (0.60%)

ANTM

Anthem

$190.17

-3.19 (-1.65%)

HNT

Health Net

CNC

Centene

$84.15

1.15 (1.39%)

MOH

Molina Healthcare

$71.33

0.02 (0.03%)

UNH

UnitedHealth

$185.25

-1.25 (-0.67%)

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

X

U.S. Steel

$22.25

1.18 (5.60%)

AKS

AK Steel

$6.65

0.35 (5.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 02

    Aug

  • 14

    Aug

  • 23

    Oct

  • 03

    Feb

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

ANTM

Anthem

$190.17

-3.19 (-1.65%)

18:58
06/23/17
06/23
18:58
06/23/17
18:58
Periodicals
Anthem to pay $115M to settle data breach lawsuits, Reuters reports »

Anthem has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVU

Supervalu

$2.94

-0.04 (-1.34%)

18:26
06/23/17
06/23
18:26
06/23/17
18:26
Hot Stocks
Supervalu completes acquisition of Unified Grocers »

Supervalu announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$70.52

0.04 (0.06%)

18:14
06/23/17
06/23
18:14
06/23/17
18:14
Periodicals
Gilead no longer a 'value trap,' Barron's reports »

Consistent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

, EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

18:07
06/23/17
06/23
18:07
06/23/17
18:07
Hot Stocks
Southern National Bancorp, Eastern Virginia Bankshares complete merger »

Southern National Bancorp…

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$104.84

0.3 (0.29%)

17:56
06/23/17
06/23
17:56
06/23/17
17:56
Hot Stocks
IAC will not pursue plan to create new class of non-voting stock »

IAC's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGL

Engility

$27.37

0.26 (0.96%)

17:50
06/23/17
06/23
17:50
06/23/17
17:50
Hot Stocks
Engility to eliminate position of president, COO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

ADM

Archer Daniels

$41.16

0.13 (0.32%)

17:48
06/23/17
06/23
17:48
06/23/17
17:48
Hot Stocks
ADM Animal Nutrition recalls Rough-N-Ready cattle feed over monensin concerns »

ADM Animal Nutrition, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$35.24

0.03 (0.09%)

17:30
06/23/17
06/23
17:30
06/23/17
17:30
Syndicate
Breaking Syndicate news story on Voya Financial »

Voya Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

, TBK

Triumph Bancorp

17:19
06/23/17
06/23
17:19
06/23/17
17:19
Hot Stocks
Independent Bank to sell nine Colorado branches to TBK Bank »

Independent Bank (IBTX)…

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

TBK

Triumph Bancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

WUBA

58.com

$43.30

0.87 (2.05%)

17:11
06/23/17
06/23
17:11
06/23/17
17:11
Hot Stocks
Breaking Hot Stocks news story on 58.com »

General Atlantic reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

, LGF.B

Lionsgate

$25.38

0.34 (1.36%)

17:10
06/23/17
06/23
17:10
06/23/17
17:10
Hot Stocks
Box Office Battle: 'Transformers' expected to top 'Cars 3,' 'Wonder Woman' »

Viacom (VIA, VIAB)…

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

LGF.B

Lionsgate

$25.38

0.34 (1.36%)

DIS

Disney

$104.36

0.14 (0.13%)

VIAB

Viacom

$34.11

-0.01 (-0.03%)

LGF.A

Lionsgate

$27.07

0.31 (1.16%)

VIA

Viacom

$39.15

0.1 (0.26%)

SNE

Sony

$38.52

0.11 (0.29%)

FOX

21st Century Fox

$26.93

0.3 (1.13%)

TWX

Time Warner

$99.70

0.3 (0.30%)

CMCSA

Comcast

$39.50

-0.44 (-1.10%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

NVUS

Novus Therapeutics

$6.00

-0.04 (-0.66%)

17:07
06/23/17
06/23
17:07
06/23/17
17:07
Syndicate
Breaking Syndicate news story on Novus Therapeutics  »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.88

0.03 (3.53%)

17:05
06/23/17
06/23
17:05
06/23/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Interpace Diagnostics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.95

0.26 (1.77%)

17:02
06/23/17
06/23
17:02
06/23/17
17:02
Hot Stocks
Monmouth Real Estate acquires building in Texas for $50.6M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

ARCW

ARC Group

$3.55

0.15 (4.41%)

17:01
06/23/17
06/23
17:01
06/23/17
17:01
Hot Stocks
ARC Group names Drew Kelley as Interim CEO, effective July 1 »

ARC Group Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$4.41

-0.08 (-1.78%)

16:55
06/23/17
06/23
16:55
06/23/17
16:55
Syndicate
PAVmed announces effectiveness of Form S-1 resale registration statement »

PAVmed announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFSF

MutualFirst Financial

$36.15

0.9 (2.55%)

16:48
06/23/17
06/23
16:48
06/23/17
16:48
Hot Stocks
MutualFirst Financial senior executives enter 10b5-1 trading plans »

On June 23, David Heeter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.10

0.25 (0.78%)

16:46
06/23/17
06/23
16:46
06/23/17
16:46
Hot Stocks
Cisco CEO Charles Robbins enters 10b5-1 trading plan »

On June 21, Charles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SITO

SITO Mobile

$3.66

0.02 (0.55%)

16:43
06/23/17
06/23
16:43
06/23/17
16:43
Hot Stocks
SITO Mobile chairman Paul Pressler resigns »

Effective as of June 23,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$517.33

-9.2 (-1.75%)

, CELG

Celgene

$134.31

0.63 (0.47%)

16:41
06/23/17
06/23
16:41
06/23/17
16:41
General news
S&P sees mild weekly gain, Nasdaq outperforms as biotech shines »

The S&P finished the…

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

GILD

Gilead

$70.54

0.06 (0.09%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

ABBV

AbbVie

$72.64

-0.54 (-0.74%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BA

Boeing

$202.23

2.79 (1.40%)

ORCL

Oracle

$50.95

0.65 (1.29%)

EQT

EQT Corporation

$56.19

4.16 (8.00%)

RICE

Rice Energy

$25.65

1.62 (6.74%)

SYK

Stryker

$141.12

-0.1 (-0.07%)

NVDQ

Novadaq

$11.78

-0.02 (-0.17%)

PRXL

Parexel

$86.80

-0.31 (-0.36%)

LH

LabCorp

$151.62

1.28 (0.85%)

ICLR

ICON plc

$96.37

-0.26 (-0.27%)

NKE

Nike

$52.85

0.45 (0.86%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AMD

AMD

$14.15

-0.23 (-1.60%)

LZB

La-Z-Boy

$32.30

0.7 (2.22%)

RHT

Red Hat

$99.42

0.54 (0.55%)

AAL

American Airlines

$48.63

-0.34 (-0.69%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

THC

Tenet

$18.52

-0.38 (-2.01%)

SCS

Steelcase

$13.65

-0.45 (-3.19%)

ACN

Accenture

$122.74

0.66 (0.54%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 07

    Jul

  • 13

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

  • 29

    Aug

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 23

    Oct

  • 14

    Nov

  • 15

    Jan

  • 03

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

16:39
06/23/17
06/23
16:39
06/23/17
16:39
General news
Moody's raises Greece rating to Caa2 from Caa3, outlook to positive from stable »

Moody's has upgraded…

CFCO

CF Corporation

$11.42

-0.04 (-0.35%)

16:38
06/23/17
06/23
16:38
06/23/17
16:38
Hot Stocks
Breaking Hot Stocks news story on CF Corporation »

Mason Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.